Publication | Open Access

Antifibrinolytic therapy during cardiopulmonary bypass reduces proinflammatory cytokine levels: a randomized, double-blind, placebo-controlled study of ϵ-aminocaproic acid and aprotinin

Inflammationϵ-Aminocaproic AcidAntifibrotic TherapyAnti-inflammatoryCardiovascular DiseaseAntifibrinolytic TherapyPharmacologyCardiovascular PharmacologyPlacebo-controlled StudyPharmacotherapyMedicineAnticoagulantAnesthesiology